These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 234547)

  • 1. Hyperreactive arterial endothelial cells in atherogenesis and cyclic AMP phosphodiesterase inhibitor in prevention and treatment of atherosclerotic disorders.
    Shimamoto T
    Jpn Heart J; 1975 Jan; 16(1):76-97. PubMed ID: 234547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperreactive arterial endothelial cells: a clue for the treatment of atherosclerosis.
    Shimamoto T; Hidaka H; Moriya K; Kobayashi M; Takahashi T; Numano F
    Ann N Y Acad Sci; 1976; 275():266-85. PubMed ID: 188368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of antiaggregating activity of adenosine by a phosphodiesterase inhibitor, EG626 (oxagrelate), in human platelets in vitro.
    Azuma H; Takashima Y; Ishikawa M; Yamakado T
    Jpn J Pharmacol; 1984 Feb; 34(2):159-70. PubMed ID: 6205194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs and foods on contraction of endothelial cells as a key mechanism in atherogenesis and treatment of atherosclerosis with endothelial-cell relaxants (cyclic AMP phosphodiesterase inhibitors).
    Shimamoto T
    Adv Exp Med Biol; 1975; 60():77-105. PubMed ID: 167561
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperreactive arterial endothelial cells in atherogenesis. Effect of smooth muscle relaxants.
    Shimamoto T; Moriya K; Kobayashi DV; Takahashi T; Numano F
    Adv Exp Med Biol; 1977; 82():234-6. PubMed ID: 920366
    [No Abstract]   [Full Text] [Related]  

  • 6. Phagocytosis of outer segments by cultured rat pigment epithelium. Reduction by cyclic AMP and phosphodiesterase inhibitors.
    Edwards RB; Bakshian S
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1184-8. PubMed ID: 6158495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of atherosclerosis.
    Numano F
    Jpn Circ J; 1980 Jan; 44(1):55-68. PubMed ID: 6245288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunofluorescent demonstration of plasma protein entry into arterial wall by cholesterol, epinephrine, norepinephrine and angiotensin II.
    Shimamoto T; Kobayashi M; Numano F
    Acta Pathol Jpn; 1975 Jan; 25(1):51-67. PubMed ID: 166554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of the antiatherosclerotic activity of unsymmetrical pyridinolcarbamates.
    Ito S; Kobayashi M; Ishikawa M
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1989; 23():49-58. PubMed ID: 2488963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase inhibitors: their comparative effectiveness in vitro in various organs.
    Adachi K; Numano F
    Jpn J Pharmacol; 1977 Feb; 27(1):97-103. PubMed ID: 194077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP: a potent inhibitor of DNA synthesis in cultured arterial endothelial and smooth muscle cells.
    Stout RW
    Diabetologia; 1982 Jan; 22(1):51-5. PubMed ID: 6277716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple molecular forms of phosphodiesterase and the regulation of cardiac muscle contractility.
    Weishaar RE; Kobylarz-Singer DC; Quade MM; Steffen RP; Kaplan HR
    J Cyclic Nucleotide Protein Phosphor Res; 1986-1987; 11(7):513-27. PubMed ID: 2831259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertensive arterial disease and atherogenesis. Part. 1. Intimal changes in the old, spontaneously hypertensive rat (SHR).
    Hadjiisky P; Peyri N
    Atherosclerosis; 1982 Aug; 44(2):181-99. PubMed ID: 7138619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in molecular pathology. The effects of hypertension on the arterial wall.
    Chobanian AV; Prescott MF; Haudenschild CC
    Exp Mol Pathol; 1984 Aug; 41(1):153-69. PubMed ID: 6381089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of insulin and glucose on the cells of the arterial wall: interaction of insulin with dibutyryl cyclic AMP and low density lipoprotein in arterial cells.
    Young IR; Stout RW
    Diabete Metab; 1987 Jul; 13(3 Pt 2):301-6. PubMed ID: 2820812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cyclic AMP analogues and phosphodiesterase inhibitors on K+-induced [3H]noradrenaline release from rat brain slices and on its presynaptic alpha-adrenergic modulation.
    Wemer J; Schoffelmeer AN; Mulder AH
    J Neurochem; 1982 Aug; 39(2):349-56. PubMed ID: 6283025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3':5'-cyclic-nucleotide phosphodiesterases of mammalian sera.
    Asano T; Hidaka H
    Biochim Biophys Acta; 1975 Jul; 397(1):124-33. PubMed ID: 238629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dibutyryl cyclic AMP inhibits LDL binding in cultured fibroblasts and arterial smooth muscle cells.
    Stout RW; Bierman EL
    Atherosclerosis; 1983 Jan; 46(1):13-20. PubMed ID: 6301513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of atherosclerosis.
    Ross R
    Mech Ageing Dev; 1979 Mar; 9(5-6):435-40. PubMed ID: 379462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of platelet cyclic GMP but not cyclic AMP suppression in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.
    Hirafuji M; Nezu A; Shinoda H; Minami M
    Br J Pharmacol; 1996 Jan; 117(2):299-304. PubMed ID: 8789382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.